These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 35315797

  • 1. Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: A Chinese Cross-Sectional Study.
    Meng W, Chen M, Song Y, Zhang H, Xie R, Zhang F.
    J Acquir Immune Defic Syndr; 2022 Jul 01; 90(3):360-368. PubMed ID: 35315797
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.
    Shao Y, Sun J, Kong K, Zhang R, Zhang R, Liu L, Wang J, Shen Y, Wu L, Zheng Z, Sun M, Qi T, Wang Z, Tang Y, Sun J, Song W, Yang J, Xu S, Zhao B, Shan F, Qin A, Lu H, Chen J.
    Arch Osteoporos; 2024 Jul 02; 19(1):56. PubMed ID: 38954143
    [Abstract] [Full Text] [Related]

  • 3. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
    Osteoporos Int; 2018 Mar 02; 29(3):595-613. PubMed ID: 29159533
    [Abstract] [Full Text] [Related]

  • 4. Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23.
    Chen KY, Wang CH, Lin TY, Chang CY, Liu CL, Hsiao YC, Hung CC, Wang NC.
    J Microbiol Immunol Infect; 2019 Oct 02; 52(5):693-699. PubMed ID: 30293926
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.
    Zeng YQ, Xiao J, Li CL, Wang Y, Zhang L, Pang XL, Wang D, Du J, Zhao HX.
    Chin Med J (Engl); 2020 Dec 03; 133(24):2940-2946. PubMed ID: 33278100
    [Abstract] [Full Text] [Related]

  • 9. Bone Metabolism in Men who Live with HIV Aged 50 years and Over: Impact of Infection Duration.
    Caglar B, Durcan E, Karaali R, Balkan II, Kaya SY, Yavuzer H, Konukoglu D, Aygun G, Saltoglu N, Bulut IN, Sonmezoglu K, Kadioglu P, Mete B, Tabak OF.
    Curr HIV Res; 2024 Dec 03; 22(1):65-71. PubMed ID: 38279729
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.
    Braz J Infect Dis; 2013 Dec 03; 17(6):707-11. PubMed ID: 24076108
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudine.
    Kim HS, Chin BS, Shin HS.
    J Korean Med Sci; 2013 Jun 03; 28(6):827-32. PubMed ID: 23772145
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M, Klomberg RCW, van der Veer E, Tesselaar K, Verhaar HJJ, Hoepelman AIM, Arends JE.
    Neth J Med; 2017 May 03; 75(4):138-144. PubMed ID: 28522769
    [Abstract] [Full Text] [Related]

  • 16. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.
    Casado JL, Bañon S, Andrés R, Perez-Elías MJ, Moreno A, Moreno S.
    Osteoporos Int; 2014 Mar 30; 25(3):1071-9. PubMed ID: 24057480
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.
    HIV Med; 2015 Apr 30; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.
    Tomazic J, Ul K, Volcansek G, Gorensek S, Pfeifer M, Karner P, Prezelj J, Vidmar G, Vidmar L.
    Wien Klin Wochenschr; 2007 Apr 30; 119(21-22):639-46. PubMed ID: 18043884
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
    Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L, di Gregorio S, Puig J, Gómez G, Clotet B, Negredo E, Osteoporosis Study Group.
    AIDS; 2010 Nov 27; 24(18):2827-33. PubMed ID: 21045635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.